Author

F. Relouzat

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pathology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:non-human primate· 5 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

R. Le Grand· 5 shared N. Bosquet· 3 shared R. Marlin· 3 shared V. Contreras· 3 shared C. Herate· 2 shared J. Lemaitre· 2 shared M. Galhaut· 2 shared S. van der Werf· 2 shared

Activity by Year

2021-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersPathology

R. Le Grand

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Optimization of neuromuscular blockade protocols in cynomolgus macaques: monitoring, doses and antagonism

H. Letscher, J. Lemaitre, E. Burban, R. Le Grand, P. Bruhns, F. Relouzat, A. Gouel-Cheron

This study evaluates neuromuscular blockade in cynomolgus macaques using rocuronium and atracurium, finding equivalent blockade depth at human clinical doses and successful reversal with sugammadex.

bioRxiv · Dec 22, 2023 · PreprintPathology

Multimodal mucosal and systemic immune characterization of a novel non-human primate trachoma model highlights the critical role of local immunity during acute phase disease

E. Paulet, V. Contreras, M. Galhaut, I. Rosenkrands, M. Holland, M. Burton, J. Dietrich, A.-S. Gallouët, N. Bosquet, F. Relouzat, S. Langlois, F. Follmann, R. Le Grand, M. Labetoulle, A. Rousseau

This study develops a non-human primate model of acute trachoma and characterizes the local immune response kinetics following Chlamydia trachomatis infection.

bioRxiv · Dec 5, 2023Microbiology

ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys

C. Fenwick, P. Turelli, Y. Duhoo, K. Lau, C. Herate, R. Marlin, M. Lamrayah, J. Campos, L. Leuenberger, A. Farina, c. raclot, V. Genet, F. Fiscalini, J. Cesborn, L. Perez, , G. Pantaleo

bioRxiv · Jul 18, 2023 · PreprintMicrobiology

Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate model

C. Herate, R. Marlin, F. Touret, N. D. Bosquet, F. Donati, F. Relouzat, L. Junges, M. Galhaut, O. Dehan, Q. Sconosciutti, A. Nougairede, X. de Lamballerie, S. van der Werf, R. Le Grand

This study shows Sotrovimab remains effective against SARS-CoV-2 BQ.1.1 in a non-human primate model, as measured by reduced viral replication.

bioRxiv · Feb 15, 2023Pathology

Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects Macaques from infection

G. Sulbaran, P. Maisonnasse, A. Amen, D. Guilligay, N. Bosquet, J. A. Burger, M. Poniman, M. Buisson, S. D. Dylon, T. Naninck, J. Lemaitre, W. Gros, A.-S. Gallouet, R. Marlin, C. Bouillier, , W. Weissenhorn

This study develops a synthetic SARS-CoV-2 S glycoprotein virus-like particle vaccine that protects macaques from infection through strong antibody and T cell responses.

bioRxiv · Jul 26, 2021Immunology